Physician profile
James Harris
NPI 1487654737
$1,183.85
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $324 · 2020: $34.67 · 2021: $189 · 2022: $148 · 2023: $333 · 2024: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $488.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $487.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $309.62 | 2019-2021 | |
| Boston Scientific Corporation | $197.76 | 2019-2024 | Lithovue |
| Convatec INC. | $174.77 | 2019-2023 | |
| Abbvie INC. | $83.87 | 2021-2023 | |
| 180 Medical, INC. | $62.14 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $47.57 | 2023 | Gemtesa |
| Abc Home Medical Supply, INC. | $42.40 | 2022 | |
| Angiodynamics, INC. | $41.09 | 2023 | Nanoknife |
| Urovant Sciences INC | $39.21 | 2022 | |
| Endo Pharmaceuticals INC. | $29.95 | 2021-2023 | Aveed, Xiaflex |
| Procept Biorobotics Corporation | $24.22 | 2023 | Aquabeam Robotic System |
| Olympus America INC. | $24.15 | 2019 | |
| Myovant Sciences INC. | $19.22 | 2021 | |
| Tolmar, INC. | $19.06 | 2023 | |
| Pfizer INC. | $18.69 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $17.66 | 2021 | |
| Acerus Pharmaceuticals Corporation | $15.30 | 2021 | |
| Allergan, INC. | $10.85 | 2019 | |
| Bolder Surgical LLC | $6.32 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.